Skip to content

Catalyst Pharmaceuticals Inc Sustainability Reports

Catalyst Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel medicines for patients with rare diseases.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 5299004O0R5XXLA5H544

7 reports from 2018 to 2024